Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leyvraz

Showing results (361-370 of 405) with videos related to

Pageof 41
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 14, 2006
Intra-arterial hepatic fotemustine for the treatment of liver metastases from uveal melanoma: experience in 101 patientsS Peters, V Voelter, L Zografos, et al.
British Journal of Cancer|December 11, 2025
Sorafenib plus selective internal radiotherapy with <sup>90</sup>Y resin microspheres for the treatment of uveal melanoma with liver metastasis: a phase I trialGrégoire Berthod, Christophe Cisarovsky, Tatiana Petrova, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 20, 2006
New generation vaccine induces effective melanoma-specific CD8+ T cells in the circulation but not in the tumor siteVictor Appay, Camilla Jandus, Verena Voelter, et al.
International Journal of Cancer|June 11, 1996
Infrequent expression of the MAGE gene family in uveal melanomasK A Mulcahy, D Rimoldi, F Brasseur, et al.
Plos Genetics|December 31, 2020
Genomic and transcriptomic landscape of conjunctival melanomaKatarina Cisarova, Marc Folcher, Ikram El Zaoui, et al.
European Journal of Cancer (Oxford, England : 1990)|February 9, 2025
Characterizing uveal melanoma patients with peritoneal metastases: A retrospective single-center analysisStanislav Rosnev, Caroline A Peuker, Iris Piwonski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2009
Absence of progression as assessed by response evaluation criteria in solid tumors predicts survival in advanced GI stromal tumors treated with imatinib mesylate: the intergroup EORTC-ISG-AGITG phase III trialAxel Le Cesne, Martine Van Glabbeke, Jaap Verweij, et al.
European Journal of Cancer (Oxford, England : 1990)|August 6, 2023
Tumour mutational burden and survival with molecularly matched therapyTill de Bortoli, Manuela Benary, Peter Horak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2002
Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomideRoger Stupp, Pierre-Yves Dietrich, Sandrine Ostermann Kraljevic, et al.
Blood|October 25, 2008
Long-term follow-up results of IFM99-03 and IFM99-04 trials comparing nonmyeloablative allotransplantation with autologous transplantation in high-risk de novo multiple myelomaPhilippe Moreau, Frédéric Garban, Michel Attal, et al.
Pageof 41

Showing results (361-370 of 405) with videos related to

Sort By:
Pageof 41
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 14, 2006
Intra-arterial hepatic fotemustine for the treatment of liver metastases from uveal melanoma: experience in 101 patientsS Peters, V Voelter, L Zografos, et al.
British Journal of Cancer|December 11, 2025
Sorafenib plus selective internal radiotherapy with <sup>90</sup>Y resin microspheres for the treatment of uveal melanoma with liver metastasis: a phase I trialGrégoire Berthod, Christophe Cisarovsky, Tatiana Petrova, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 20, 2006
New generation vaccine induces effective melanoma-specific CD8+ T cells in the circulation but not in the tumor siteVictor Appay, Camilla Jandus, Verena Voelter, et al.
International Journal of Cancer|June 11, 1996
Infrequent expression of the MAGE gene family in uveal melanomasK A Mulcahy, D Rimoldi, F Brasseur, et al.
Plos Genetics|December 31, 2020
Genomic and transcriptomic landscape of conjunctival melanomaKatarina Cisarova, Marc Folcher, Ikram El Zaoui, et al.
European Journal of Cancer (Oxford, England : 1990)|February 9, 2025
Characterizing uveal melanoma patients with peritoneal metastases: A retrospective single-center analysisStanislav Rosnev, Caroline A Peuker, Iris Piwonski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2009
Absence of progression as assessed by response evaluation criteria in solid tumors predicts survival in advanced GI stromal tumors treated with imatinib mesylate: the intergroup EORTC-ISG-AGITG phase III trialAxel Le Cesne, Martine Van Glabbeke, Jaap Verweij, et al.
European Journal of Cancer (Oxford, England : 1990)|August 6, 2023
Tumour mutational burden and survival with molecularly matched therapyTill de Bortoli, Manuela Benary, Peter Horak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2002
Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomideRoger Stupp, Pierre-Yves Dietrich, Sandrine Ostermann Kraljevic, et al.
Blood|October 25, 2008
Long-term follow-up results of IFM99-03 and IFM99-04 trials comparing nonmyeloablative allotransplantation with autologous transplantation in high-risk de novo multiple myelomaPhilippe Moreau, Frédéric Garban, Michel Attal, et al.
Pageof 41